Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic association study of individual differences in antipsychotic treatment response
ChiCTR-RNC-09000522Phase 4Completed
- Sponsor
- Peking University Sixth Hospital
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of risperidone, olanzapine and aripiprazole in schizophrenia (3 arms), sponsored by Peking University Sixth Hospital. Primary endpoint: Positive and Negative Syndrome Scale (PANSS). Started Jan 2008; status: completed.
02
Drugs
risperidoneolanzapinearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-RNC-09000522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RNC-09000522.